Company / Working Capital per Share
Annovis Bio, Inc. Working Capital per Share History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.73
FY2023
5-year range
$0.73 / $6.46
FY2020-FY2023
Trend
-79.2%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 3 consecutive years, from $26.68 in FY2020 to $0.73 in FY2023.
Based on SEC 10-K filings.
0.73 in FY2023 with a 3-year CAGR of -69.9%.
Declined from $6.46 to $0.73 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -69.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Annovis Bio, Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2023, working capital per share decreased 79.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -9.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.73 | -79.2% |
| FY2022 | $3.50 | -45.8% |
| FY2021 | $6.46 | -75.8% |
| FY2020 | $26.68 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026